Learn more about the world’s first UVC germ-fighting robot.
When we were first awarded patents for Tru-D, and with the introduction of iTru-D, we envisioned a seamlessly connected hospital staff. Now, from the time daytime staff completes daily room disinfection routines to the time surgical services staff begins the night shift, the day’s infection control data is accessible with the click of a button.
The pioneer in the UV disinfection industry, Tru-D was introduced to the health care industry in 2007 and continues to be the gold standard in the space. Tru-D is the only device with intuitive Sensor360 technology that accurately calculates the precise dose of UV light needed to kill up to 99.9% of harmful pathogens. Operating from a single position and administering a single cycle of UV energy, Tru-D guarantees total room disinfection, including in shadowed areas.
While Tru-D has been on the market for nearly a decade, the technology behind Tru-D has a much richer history. Originally sold under Lumalier – a company with a 50-year history in the UV germicidal industry – multiple patents and more than a decade of research and clinical trials were obtained on Tru-D.
Today, Tru-D continues to be the device of choice for nearly all of the existing independent research on UV disinfection technology including the first-ever randomized clinical trial on UV disinfection. Tru-D was the sole device chosen for the $2 million study funded by the Centers for Disease Control’s Prevention Epicenter Program at Duke University, the University of North Carolina and seven other hospitals in the region. Results proved that enhanced cleaning technologies decreased the cumulative incidences of multidrug-resistant organisms by a cumulative 30 percent among patients admitted to the same room, and the largest decreases were seen when Tru-D was added to the standard cleaning protocols.
Tru-D’s effectiveness and accuracy have been supported by a number of other independent, peer-reviewed studies conducted by leading authorities in infection control and epidemiology. Third-party, peer-reviewed research using Tru-D includes published studies on Clostridium difficile (C. diff), Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant enterococci (VRE).
Bearing the marks of both Intertek and ETL safety ratings, Tru-D is a chemical-free, proven addition to any hospital’s EVS team. Tru-D’s bulbs are safe, energy efficient and are made the same way compact fluorescent bulbs already being used hospital-wide are made.
More Tru-D’s have been deployed throughout the U.S. than any of its lookalike offerings and is currently eliminating germs in hospitals in the U.S., Canada and Europe, including the National Institutes of Health, Lehigh Valley Health Network, Walter Reed Army Medical Center, Houston Methodist, University of Pittsburgh Medical Center, many VA medical centers and Nottingham University Hospitals NHS Trust.
Oftentimes, hospitals refer to their robot as “Trudi,” as she becomes an integral member of the EVS team.
To read more about Tru-D’s technology, click here or to have a Tru-D representative contact you, please e-mail us at firstname.lastname@example.org.